請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43653
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林中天 | |
dc.contributor.author | I-Han Wu | en |
dc.contributor.author | 吳依涵 | zh_TW |
dc.date.accessioned | 2021-06-15T02:25:13Z | - |
dc.date.available | 2016-08-20 | |
dc.date.copyright | 2011-08-20 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-08-17 | |
dc.identifier.citation | Ahsan, H., Ali A., Ali R. (2003). Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131(3):398-404.
Alho, H., Hemila H., Korpela H. (1994). Role of vitamin E and C, carotenoids, ubiquinone and selenium in the antioxidative defense system. Duodecim 110(17):1621-8. Amagase, H., Nance D.M. (2008). A randomized, double-blind, placebo-controlled, clinical study of the general effects of a standardized Lycium barbarum (Goji) Juice, GoChi. J Altern Complement Med 14(4):403-12. Amagase, H., Sun B., Borek C. (2009). Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults. Nutr Res 29(1):19-25. Aruoma, O.I., Halliwell B., Gajewski E., Dizdaroglu M. (1989). Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 264(34):20509-12. Aviles-Trigueros, M., Mayor-Torroglosa S., Garcia-Aviles A., Lafuente M.P., Rodriguez M.E., Miralles de Imperial J., Villegas-Perez M.P., Vidal-Sanz M. (2003). Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine. Exp Neurol 184(2):767-77. Block, F., Schwarz M., Sontag K.H. (1992). Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci Lett 144(1-2):124-6. Breithaupt, D.E., Weller P., Wolters M., Hahn A. (2004). Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography. Br J Nutr 91(5):707-13. Brubaker, R.F. (1996). Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture. Am J Ophthalmol 121(5):473-83. Buchi, E.R., Suivaizdis I., Fu J. (1991). Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 203(3):138-47. Burton, G.W. (1994). Vitamin E: molecular and biological function. Proc Nutr Soc 53(2):251-62. Cadenas, S., Rojas C., Perez-Campo R., Lopez-Torres M., Barja G. (1995). Vitamin E protects guinea pig liver from lipid peroxidation without depressing levels of antioxidants. Int J Biochem Cell Biol 27(11):1175-81. Cao, G.W., Yang W.G., Du P. (1994). Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients. Zhonghua Zhong Liu Za Zhi 16(6):428-31. Chan, H.C., Chang R.C., Koon-Ching Ip A., Chiu K., Yuen W.H., Zee S.Y., So K.F. (2007). Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol 203(1):269-73. Chao, H.M., Osborne N.N. (2001). Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors. Brain Res 904(1):126-36. Chao, J.C., Chiang S.W., Wang C.C., Tsai Y.H., Wu M.S. (2006). Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells. World J Gastroenterol 12(28):4478-84. Cheng, C.Y., Chung W.Y., Szeto Y.T., Benzie I.F. (2005). Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial. Br J Nutr 93(1):123-30. Chidlow, G., Schmidt K.G., Wood J.P., Melena J., Osborne N.N. (2002). Alpha-lipoic acid protects the retina against ischemia-reperfusion. Neuropharmacology 43(6):1015-25. Conner, E.M., Grisham M.B. (1996). Inflammation, free radicals, and antioxidants. Nutrition 12(4):274-7. Crittenden, R., Weerakkody R., Sanguansri L., Augustin M. (2006). Synbiotic microcapsules that enhance microbial viability during nonrefrigerated storage and gastrointestinal transit. Appl Environ Microbiol 72(3):2280-2. Dong, J.Z., Lu da Y., Wang Y. (2009). Analysis of flavonoids from leaves of cultivated Lycium barbarum L. Plant Foods Hum Nutr 64(3):199-204. Dreher, D., Junod A.F. (1996). Role of oxygen free radicals in cancer development. Eur J Cancer 32A(1):30-8. Eiserich, J.P., Patel R.P., O'Donnell V.B. (1998). Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 19(4-5):221-357. Engin, K.N., Yemisci B., Yigit U., Agachan A., Coskun C. (2010). Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis 16(1260-71. Esrefoglu, M., Gul M., Ates B., Batcioglu K., Selimoglu M.A. (2006). Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol 12(2):259-64. Fang, Y.Z., Yang S., Wu G. (2002). Free radicals, antioxidants, and nutrition. Nutrition 18(10):872-9. Feihl, F., Waeber B., Liaudet L. (2001). Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 91(3):179-213. Gaetani, G.F., Galiano S., Canepa L., Ferraris A.M., Kirkman H.N. (1989). Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 73(1):334-9. Gan, L., Hua Zhang S., Liang Yang X., Bi Xu H. (2004). Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int Immunopharmacol 4(4):563-9. Gan, L., Zhang S.H., Liu Q., Xu H.B. (2003). A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol 471(3):217-22. Garcia-Valenzuela, E., Shareef S., Walsh J., Sharma S.C. (1995). Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61(1):33-44. Greul, A.K., Grundmann J.U., Heinrich F., Pfitzner I., Bernhardt J., Ambach A., Biesalski H.K., Gollnick H. (2002). Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol 15(5):307-15. Grozdanic, S.D., Betts D.M., Sakaguchi D.S., Allbaugh R.A., Kwon Y.H., Kardon R.H. (2003). Laser-induced mouse model of chronic ocular hypertension. Invest Ophthalmol Vis Sci 44(10):4337-46. Grozdanic, S.D., Matic M., Betts D.M., Sakaguchi D.S., Kardon R.H. (2007). Recovery of canine retina and optic nerve function after acute elevation of intraocular pressure: implications for canine glaucoma treatment. Vet Ophthalmol 10 Suppl 1(101-7. Ha, K.T., Yoon S.J., Choi D.Y., Kim D.W., Kim J.K., Kim C.H. (2005). Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 96(3):529-35. Halliwell, B. (1993a). The chemistry of free radicals. Toxicol Ind Health 9(1-2):1-21. Halliwell, B. (1993b). Free radicals and vascular disease: how much do we know? BMJ 307(6909):885-6. Halliwell, B. (1993c). The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 (Suppl 1):118-26. Halliwell, B., Murcia M.A., Chirico S., Aruoma O.I. (1995). Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit Rev Food Sci Nutr 35(1-2):7-20. Hippeli, S., Elstner E.F. (1999). Transition metal ion-catalyzed oxygen activation during pathogenic processes. FEBS Lett 443(1):1-7. Hosotani, K., Yoshida M., Kitagawa M. (2005). Effects of administration of beta-carotene, ascorbic acid, persimmons, and pods on antioxidative ability in UV-irradiated ODS rats. Int J Vitam Nutr Res 75(4):227-34. Huang, B., Zhang J., Hou J., Chen C. (2003). Free radical scavenging efficiency of Nano-Se in vitro. Free Radic Biol Med 35(7):805-13. Hughes, W.F. (1991). Quantitation of ischemic damage in the rat retina. Exp Eye Res 53(5):573-82. Jacob, R.A., Burri B.J. (1996). Oxidative damage and defense. Am J Clin Nutr 63(6):985S-90S. Jing, L., Cui G., Feng Q., Xiao Y. (2009). Evaluation of hypoglycemic activity of the polysaccharides extracted from Lycium barbarum. Afr J Tradit Complement Altern Med 6(4):579-84. Johnson, B., House P., Morgan W., Sun X., Yu D.Y. (1999). Developing laser-induced glaucoma in rabbits. Aust N Z J Ophthalmol 27(3-4):180-3. Johnson, E.C., Morrison J.C., Farrell S., Deppmeier L., Moore C.G., McGinty M.R. (1996). The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp Eye Res 62(6):663-74. Junghans, A., Sies H., Stahl W. (2001). Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391(2):160-4. Kalinina, E.V., Chernov N.N., Aleud R., Novichkova M.D., Saprin A.N., Berezov T.T. (2010). Current views on antioxidative activity of glutathione and glutathione-depending enzymes. Vestn Ross Akad Med Nauk3):46-54. Kankofer, M. (2001). Antioxidative defence mechanisms against reactive oxygen species in bovine retained and not-retained placenta: activity of glutathione peroxidase, glutathione transferase, catalase and superoxide dismutase. Placenta 22(5):466-72. Kim, S.Y., Choi Y.H., Huh H., Kim J., Kim Y.C., Lee H.S. (1997). New antihepatotoxic cerebroside from Lycium chinense fruits. J Nat Prod 60(3):274-6. Koner, B.C., Banerjee B.D., Ray A. (1997). Effects of in-vivo generation of oxygen free radicals on immune responsiveness in rabbits. Immunol Lett 59(3):127-31. Lafuente, M.P., Villegas-Perez M.P., Sobrado-Calvo P., Garcia-Aviles A., Miralles de Imperial J., Vidal-Sanz M. (2001). Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 42(9):2074-84. Lam, A.Y., Elmer G.W., Mohutsky M.A. (2001). Possible interaction between warfarin and Lycium barbarum L. Ann Pharmacother 35(10):1199-201. Larsen, A.K., Osborne N.N. (1996). Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci 37(13):2603-11. Leung, H., Hung A., Hui A.C., Chan T.Y. (2008). Warfarin overdose due to the possible effects of Lycium barbarum L. Food Chem Toxicol 46(5):1860-2. Levin, L.A. (2003). Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol 48 Suppl 1(S21-4. Li, Z., Peng G., Zhang S. (1998). [Separation and determination of carotenoids in Fructus lycii by isocratic non-aqueous reversed-phase liquid chromatography]. Se Pu 16(4):341-3. Luo, Q., Cai Y., Yan J., Sun M., Corke H. (2004). Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 76(2):137-49. Lynch, D.R., Dawson T.M. (1994). Secondary mechanisms in neuronal trauma. Curr Opin Neurol 7(6):510-6. Marnett, L.J. (2000). Oxyradicals and DNA damage. Carcinogenesis 21(3):361-70. Martinez-Cayuela, M. (1995). Oxygen free radicals and human disease. Biochimie 77(3):147-61. McKinnon, S.J. (1997). Glaucoma, apoptosis, and neuroprotection. Curr Opin Ophthalmol 8(2):28-37. Miles, A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. (1996). Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 271(1):40-7. Miller, P.E., Ofri R., Slatter D.H., 2008. Glaucoma: Slatter's fundamentals of veterinary ophthalmology, 4th ed. St. Louis, Mo., Saunders Elsevier, 230-257. Murakami, T., Nagamura Y., Hirano K. (1998). The recovering effect of betaine on carbon tetrachloride-induced liver injury. J Nutr Sci Vitaminol (Tokyo) 44(2):249-55. Nagele, A., Lengfelder E. (1996). The superoxide dismutase-mimic copper-putrescine-pyridine suppresses lipid peroxidation in CHO cells. Implications for its prooxidative and antioxidative mechanisms of action. Free Radic Res 25(2):109-15. Nordberg, J., Arner E.S. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31(11):1287-312. Nowicka, G., Panczenko-Kresowska B. (2003). Flavonoids: antioxidative compounds and their role in prevention of ischemic heart disease. Pol Merkur Lekarski 15(89):441-4. Oberdorster, G., Oberdorster E., Oberdorster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823-39. Ohia, S.E., Opere C.A., Leday A.M. (2005). Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 579(1-2):22-36. Osborne, N.N., Casson R.J., Wood J.P., Chidlow G., Graham M., Melena J. (2004a). Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23(1):91-147. Osborne, N.N., Cazevieille C., Carvalho A.L., Larsen A.K., DeSantis L. (1997). In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 751(1):113-23. Osborne, N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., Nash M.S. (1999). Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 43 Suppl 1(S102-28. Osborne, N.N., Wood J.P., Chidlow G., Casson R., DeSantis L., Schmidt K.G. (2004b). Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Res Bull 62(6):525-8. Peng, Y., Ma C., Li Y., Leung K.S., Jiang Z.H., Zhao Z. (2005). Quantification of zeaxanthin dipalmitate and total carotenoids in Lycium fruits (Fructus Lycii). Plant Foods Hum Nutr 60(4):161-4. Potterat, O. (2010). Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med 76(1):7-19. Racek, J., Holecek V., Trefil L. (2000). Antioxidative properties of ascorbic acid. Cas Lek Cesk 139(19):583-7. Rosenbaum, D.M., Rosenbaum P.S., Singh M., Gupta G., Gupta H., Li B., Roth S. (2001). Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol 21(1):62-8. Saito, S., Ohashi M., Naito A., Fukaya Y., Suzuki Y., Araie M. (2005). Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells. Jpn J Ophthalmol 49(5):371-6. Salim, A.S. (1993). The permissive role of oxygen-derived free radicals in the development of colonic cancer in the rat. A new theory for carcinogenesis. Int J Cancer 53(6):1031-5. Sawada, A., Neufeld A.H. (1999). Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res 69(5):525-31. Schnackenberg, C.G. (2002). Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol 2(2):121-5. Selles-Navarro, I., Villegas-Perez M.P., Salvador-Silva M., Ruiz-Gomez J.M., Vidal-Sanz M. (1996). Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci 37(10):2002-14. Shareef, S.R., Garcia-Valenzuela E., Salierno A., Walsh J., Sharma S.C. (1995). Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 61(3):379-82. Shibuki, H., Katai N., Kuroiwa S., Kurokawa T., Arai J., Matsumoto K., Nakamura T., Yoshimura N. (2002). Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 43(2):528-36. St Angelo, A.J. (1996). Lipid oxidation on foods. Crit Rev Food Sci Nutr 36(3):175-224. Sugiyama, K., Gu Z.B., Kawase C., Yamamoto T., Kitazawa Y. (1999). Optic nerve and peripapillary choroidal microvasculature of the rat eye. Invest Ophthalmol Vis Sci 40(13):3084-90. Takizawa, M., Komori K., Tampo Y., Yonaha M. (2007). Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductase. Toxicol In Vitro 21(3):355-63. Tezel, G. (2006). Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25(5):490-513. Tian, M., Wang M. (2006). Studies on extraction, isolation and composition of Lycium barbarum polysaccharides. Zhongguo Zhong Yao Za Zhi 31(19):1603-7. Wang, N.T., Lin H.I., Yeh D.Y., Chou T.Y., Chen C.F., Leu F.C., Wang D., Hu R.T. (2009). Effects of the antioxidants lycium barbarum and ascorbic acid on reperfusion liver injury in rats. Transplant Proc 41(10):4110-3. Wein, F.B., Levin L.A. (2002). Current understanding of neuroprotection in glaucoma. Curr Opin Ophthalmol 13(2):61-7. Wink, D.A., Mitchell J.B. (1998). Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25(4-5):434-56. Wood, J.P., Schmidt K.G., Melena J., Chidlow G., Allmeier H., Osborne N.N. (2003). The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 76(4):505-16. Wu, S.J., Ng L.T., Lin C.C. (2004). Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos. Phytother Res 18(12):1008-12. Xu, Q., Wang X.Q., Tian H.Q. (2006). [The features of distribution of polysaccharide and lipid in the developing anther of Lycium barbarum L]. Fen Zi Xi Bao Sheng Wu Xue Bao 39(2):103-10. Yoshida, S., Kumakura F., Komatsu I., Arai K., Onuma Y., Hojo H., Singh B.G., Priyadarsini K.I., Iwaoka M. (2011). Antioxidative glutathione peroxidase activity of selenoglutathione. Angew Chem Int Ed Engl 50(9):2125-8. Yu, M.S., Ho Y.S., So K.F., Yuen W.H., Chang R.C. (2006). Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum. Int J Mol Med 17(6):1157-61. Yu, M.S., Leung S.K., Lai S.W., Che C.M., Zee S.Y., So K.F., Yuen W.H., Chang R.C. (2005). Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 40(8-9):716-27. Zhang, M., Chen H., Huang J., Li Z., Zhu C., Zhang S. (2005). Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci 76(18):2115-24. Zhou, M., Chen Y. (1984). [Glutathione peroxidase--an antioxidative enzyme]. Sheng Li Ke Xue Jin Zhan 15(4):348-51. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43653 | - |
dc.description.abstract | 青光眼因為高眼壓會造成視網膜缺血並導致視神經傷害進而視神經細胞死亡。在亞洲國家,枸杞被認為有滋肝補腎與改善視力的功能已經超過2500年之久,此外,近年來奈米技術一直是個熱門話題,認為更小的粒子可能具有更多的有效生物利用度,值得進一步的研究。介質研磨的方式,可以將物質的粒徑減小到奈米/次微米等級,使物質具有較高生物活性成分(膳食纖維,總類胡蘿蔔素,β物胡蘿蔔素和粗多醣)之萃取效率。
為了了解不同粒徑的中草藥枸杞在青光眼高眼壓導致的視網膜缺血、神經細胞的死亡和氧化性傷害等之保護效果,我們建立高眼壓大鼠動物模式,並分析高眼壓大鼠動物模式之視網膜病變特徵,作為青光眼和視網膜缺血傷害之預防與治療研究的基礎。本實驗成功建立穩定高眼壓視網膜缺血大鼠模式,並分析高眼壓大鼠動物模式之視網膜病變特徵,利用視網膜電波圖測量、組織病理學分析、抗氧化物(總麩胱甘肽、超氧化物歧化酶、過氧化氫酶)與脂質過氧化產物丙二醛之濃度測定,評估奈米/次微米枸杞對於實驗性視網膜缺血動物模式造成的視網膜傷害是否具有神經保護之功能。 投予不同粒徑大小不同劑量(細碎非奈米化、介質研磨奈米化;500 mg/kg、250 mg/kg、100 mg/kg)之枸杞,評估是否對於視網膜缺血性病變有神經保護與對抗氧化傷害的效果。所有枸杞治療組的視網膜電波a波與b波相較於高眼壓視網膜缺血大鼠的未治療組都有保留波幅的效果: a波可以保留約55~60%的波幅,b波可以保留約43~62%的波幅。所有枸杞治療組對於視網膜缺血病變都具有保留視網膜功能的作用。其中以250 mg/kg之介質研磨奈米化枸杞對於視網膜電波圖b波具有最好的保護效果。 在抗氧化傷害方面,不同粒徑大小不同劑量枸杞對於視網膜內抗氧化物(總麩胱甘肽、超氧化物歧化酶、過氧化氫酶)相較於高眼壓視網膜缺血大鼠未治療組均有提升,而代表氧化壓力之脂質過氧化產物丙二醛相較於高眼壓視網膜缺血大鼠未治療組皆有下降,不管細碎非奈米化或是介質研磨奈米化枸杞皆具有保護視網膜的效果。整體來說,250 mg/kg之介質研磨奈米化枸杞與500 mg/kg之細碎非奈米化枸杞相較與其他實驗組,具有最好的抗氧化效果。在血漿中,抗氧化物總麩胱甘肽與過氧化氫酶在傷害未治療組與各治療組間並未見明顯差異,在超氧化物歧化酶與脂質過氧化產物丙二醛則可觀察到投予枸杞皆具有提升抗氧化酵素與降低氧化傷害的能力。綜合結果顯示,枸杞在高眼壓視網膜缺血時對視網膜結構型態及功能與對抗氧化傷害能力上均發現有保護的效果,尤以250 mg/kg之介質研磨奈米化枸杞之保護效果最佳。 | zh_TW |
dc.description.abstract | Ocular hypertension or glaucoma results in retinal ischemia and consequent death of optical neural cells. Lycium barbarum (LB) has been known for nourishing the liver and kidney, improving visual acuity for more than 2,500 years in oriental countries. Further, nanotechnology has been minimize particle size in order to achieve more effective bioavailability. Media milling of LB who used to reduce the material size to nano/submicron scale, which was attributed to higher extractive efficiency of bioactive components (dietary fiber, total carotenoids, beta-carotene and crude polysaccharides).
To evaluate the neuroprotective effect of the Chinese herb Lycium barbarum with different particle sizes, we established an experimental rat model of ocular hypertension to evaluate features of retinal ischemia as a basis of further research in prevention and management of retinal ischemia. A stable animal model of ocular hypertension has been successfully established and characterized in the rat. In this study, we adopted electroretinography (ERG), histopathological analysis, and assayed for levels of antioxidants (Reduced glutathione and glutathione, GSH and GSSH), antioxidative enzymes (Catalase and superoxide dismutase, SOD) and peroxidants (Malondialdehyde, MDA) to evaluate the neuroprotective effect of nano/submicron LB on retinal functions in an experimental model of retinal ischemia. With different particle sizes (blended or milled) and different doses (500 mg/kg、250 mg/kg、100 mg/kg) of LB, we evaluated its neural protective and antioxidative effects on retinal ischemia. The amplitude of a and b waves were preserved in rats treated with blended or milled LB groups of different doses compared with untreated group in a wave (55-60%) and b wave (43-62%). In all LB treated groups, the preservation of retinal function following retinal ischemia was observed. The best neuroprotective effect in b-wave amplitudes of ERG was observed in the 250 mg/kg milled LB group. In terms of antioxidative capacity of retina, levels of GSSH+GSH, SOD, and catalase of all LB groups were higher than those in untreated groups, and the MDA was lower than that in untreated groups. Blended and milled L. barbarum both protected retina. To sum up, the better antioxidative effect was observed in the 250 mg/kg milled and 500 mg/kg blended LB than other group. In the plasma, there was no significant difference in levels of GSSH+GSH and catalase between the LB treated groups and untreated groups. There was higher levels of SOD and lower levels of MDA in the plasma of LB treated groups compared with untreated group. In conclusion, LB, especially 250 mg/kg milled LB, provided retinal neuroprotective effects in preservation of retinal structure and function with improved antioxidative capacity in the rats with high intraocular pressure induced retinal ischemia. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T02:25:13Z (GMT). No. of bitstreams: 1 ntu-100-R98643008-1.pdf: 7650986 bytes, checksum: fe0aad4e6e79409ef1ade6099561aa98 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 目錄
口試委員會審定書............................................................................ i 誌謝.................................................................................................. ii 中文摘要.......................................................................................... iii 英文摘要.......................................................................................... v 第一章 序言.................................................................................... 1 第一節 前言..................................................................................... 1 第二節 研究目的............................................................................. 2 第二章 文獻探討............................................................................ 3 第一節 青光眼疾病介紹與治療....................................................... 3 第二節 視網膜的正常結構與血流供應系統..................................... 5 第三節 視網膜缺血再灌流病變模式與視網膜細胞凋亡機制............ 7 3-1 視網膜缺血再灌流病變模式..................................................... 7 3-2 視網膜細胞凋亡機制................................................................ 9 第四節 枸杞化學成份之簡介......................................................... 10 第五節 枸杞在各化學成份的藥理活性........................................... 13 第六節 自由基與氧化傷害............................................................. 14 6-1 超氧陰離子(Superoxide, O2•_)....................................... 15 6-2 過氧化氫(Hydrogen peroxide, H2O2)............................ 16 6-3 羥基自由基(Hydroxyl radical,•HO).................................. 16 6-4 一氧化氮(Nitric oxide,•NO )............................................. 17 第七節 抗氧化保護系統................................................................. 17 7-1 酵素型抗氧化防禦系統.......................................................... 18 7-1.1 超氧化物歧化酶(Superoxide dismutase, SOD)........... 18 7-1.2 麩胱甘肽過氧化酶(Glutathione peroxidase, GPx)...... 18 7-1.3 過氧化氫酶(Catalase)................................................... 19 7-2 非酵素性抗氧化防禦系統....................................................... 19 7-2.1 維生素E(Vitamin E)........................................................ 19 7-2.2 抗壞血酸 (Ascorbic acid, AA)...................................... 19 7-2.3 麩胱甘肽(Glutathione, GSH)........................................ 19 7-2.4 類黃酮化合物(Flavonoids compounds)....................... 20 7-2.5 類胡蘿蔔素(Carotenoids).............................................. 20 第八節 奈米科技與食品應用......................................................... 21 第三章 實驗材料與方法................................................................ 22 第一節 實驗架構........................................................................... 22 第二節 實驗進程........................................................................... 22 第三節 實驗材料........................................................................... 23 3-1 實驗動物................................................................................ 23 3-2 細碎非奈米化(Blended)枸杞與介質研磨奈米化(Milled)枸杞之製備.................................................................................... 23 3-2.1 細碎非奈米化枸杞之製備..................................................... 23 3-2.2 介質研磨奈米化枸杞之製備................................................. 24 3-3 枸杞之餵食............................................................................. 24 3-4 血液樣本之製備...................................................................... 24 3-5 視網膜樣本之製備................................................................... 24 第四節 實驗分組............................................................................25 4-1 前導試驗分組.......................................................................... 25 4-2 不同劑量之細碎非奈米化與介質研磨奈米化枸杞投與劑量之實驗分組............................................................................................ 25 第五節 高眼壓視網膜缺血再灌流性病變模組之建立.................... 25 第六節 視網膜電波圖之記錄與分析.............................................. 26 6-1 視網膜電波圖之記錄.............................................................. 26 6-2 視網膜電波圖之分析.............................................................. 27 第七節 組織病理之分析................................................................ 27 第八節 抗氧化指標分析................................................................ 28 8-1 抗氧化物總麩胱甘肽(GSSG+GSH)的測定....................... 28 8-2 超氧化物歧化酶(Superoxide Dismutase, SOD )活性測定................................................................................................... 28 8-3 過氧化氫酶(Catalase)活性測定....................................... 28 8-4 脂質過氧化產物丙二醛(Malondialdehyde, MDA)的測定................................................................................................... 29 第九節 統計分析方式.................................................................... 29 第四章 實驗結果........................................................................... 30 第一節 穩定大鼠視網膜缺血再灌流高眼壓模式之建立…….......... 30 1-1 大鼠視網膜缺血再灌流高眼壓模式之閃光式視網膜電波圖記錄................................................................................................... 30 1-1.1 傷害後視網膜電波圖a、b波之振幅................................ 30 1-1.2 傷害後視網膜電波圖a、b波之波型................................ 30 1-2 大鼠視網膜缺血再灌流高眼壓模式之視網膜組織病理學分析..31 1-2.1 視網膜各層厚度與全厚度之數據分析.................................. 31 第二節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化與介質研磨奈米化枸杞的大鼠各週體重變化圖表........................................................................................... 33 第三節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞之視網膜電波圖實驗結果.................................................................................... 33 3-1 視網膜電波圖在治療前與治療後8週之比較........................... 33 3-1.1 視網膜缺血再灌流傷害未治療餵食生理食鹽水組(IR injury, n=9)............................................................................................. 33 3-1.2 正常控制組(Normal control, n=6)................................. 33 3-1.3 餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞組...................................................................... 34 3-1.4 餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之介質研磨奈米化枸杞組.................................................................. 34 3-1.5 餵食高劑量(500 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞組間之比較.................................................................. 35 3-1.6 餵食中劑量(250 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞組間之比較.................................................................. 36 3-1.7 餵食低劑量(100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞組間之比較.................................................................. 36 第四節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞之視網膜厚度實驗結果........................................................................................ 38 4-1 視網膜全厚度在治療後8週之結果比較.................................... 39 4-2 視網膜內核層厚度在治療後8週之結果比較............................ 39 4-3 視網膜內叢狀層與外核層之比值在治療後8週之結果比較....... 39 第五節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞治療後8週之抗氧化物總麩胱甘肽(GSH+GSSH) 之濃度比較…........................ 40 第六節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞治療後8週之抗氧化物過氧化氫酶(Catalase)在治療後8週之濃度比較............ 40 第七節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞治療後8週之抗氧化物超氧化物歧化酶(SOD)在治療後8週之活性比較............. 41 第八節 給予餵食不同劑量(500 mg/kg、250 mg/kg 、100 mg/kg)之細碎非奈米化枸杞與介質研磨奈米化枸杞治療後8週之脂質過氧化產物丙二醛在治療後8週之濃度比較................................ 41 第五章 討論................................................................................... 42 第一節 高眼壓視網膜缺血再灌流性病變大鼠模式之建立............... 42 第二節 抗氧化指標之代表意義....................................................... 44 第三節 視網膜缺血再灌流性病變與過氧化物、抗氧化物之相關性................................................................................................... 44 第四節 細碎非奈米化枸杞與介質研磨奈米化枸杞對高眼壓缺血視網膜的保護效果................................................................................. 45 第五節 細碎非奈米化枸杞與介質研磨奈米化枸杞抗氧化能力之比較................................................................................................... 46 第六節 奈米微粒的毒性與安全性.................................................. 48 參考文獻........................................................................................ 49 附錄—圖目錄................................................................................ xiv 附錄—表目錄................................................................................ xvi | |
dc.language.iso | zh-TW | |
dc.title | 奈米與次微米枸杞對大鼠視網膜缺血再灌流病變模式之神經保護效力 | zh_TW |
dc.title | The Neuroprotective Effect of Nano/submicron and Blended Lycium barbarum for Experiment Retinal Ischemia and Reperfusion Injury in Rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李憶菁,劉振軒,詹東榮 | |
dc.subject.keyword | 視網膜病變、青光眼、視網膜缺血、奈米技術、神經保護、枸杞、抗氧化, | zh_TW |
dc.subject.keyword | Retinopathy, Glaucoma, Retinal ischemia, Nanotechnology, Neuroprotection, Lycium barbarum, Antioxidant, | en |
dc.relation.page | 83 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-08-17 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床動物醫學研究所 | zh_TW |
顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 7.47 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。